158 related articles for article (PubMed ID: 21157300)
1. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
Nielsen VG; George SJ
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
[TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
4. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
Nielsen VG; Khan ES; Kirklin JK; George JF
Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide-releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in diluted plasma in vitro.
Nielsen VG; Green P; Green M; Martin-Ross A; Khan ES; Kirklin JK; George JF
J Trauma; 2011 Apr; 70(4):939-47. PubMed ID: 20693919
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
Nielsen VG; Khan ES; Kirklin JK; George JF
Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
11. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
[TBL] [Abstract][Full Text] [Related]
13. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
Nielsen VG
Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
[TBL] [Abstract][Full Text] [Related]
14. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):41-5. PubMed ID: 19923981
[TBL] [Abstract][Full Text] [Related]
15. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma.
Nielsen VG
J Heart Lung Transplant; 2006 Nov; 25(11):1344-52. PubMed ID: 17097499
[TBL] [Abstract][Full Text] [Related]
16. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
Nielsen VG
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
[TBL] [Abstract][Full Text] [Related]
17. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
[TBL] [Abstract][Full Text] [Related]
18. The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2.
Machovec KA; Ushakumari DS; Welsby IJ; Nielsen VG
Thromb Res; 2012 Jun; 129(6):793-6. PubMed ID: 21872302
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and Factor XIII deficient plasmas.
Nielsen VG; Kirklin JK; George JF; Messinger JD
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):101-5. PubMed ID: 19844175
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits.
Nielsen VG; Chawla N; Mangla D; Gomes SB; Arkebauer MR; Wasko KA; Sadacharam K; Vosseller K
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):756-9. PubMed ID: 22008906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
